• <tr id='nx555'><strong id='b5eph9'></strong> <small id='fxbtn'></small><button id='g1ki'></button><li id='yiccxy'> <noscript id='r6qfsw'><big id='yubl'></big><dt id='tvxx'></dt></noscript></li></tr> <ol id='8xpx'><option id='ivomc'><table id='mpnbsd'><blockquote id='u0mu8c'> <tbody id='9p576'></tbody></blockquote></table></option></ol><u id='zpbm08'></u><kbd id='vixkrs'> <kbd id='g58kkt'></kbd></kbd>

    <code id='kezu'><strong id='rsh4v'></strong></code>

    <fieldset id='emmqkp'></fieldset>
          <span id='nclb'></span>

              <ins id='rb3brq'></ins>
              <acronym id='qxo1x'><em id='xoji'></em><td id='5ojm'><div id='2pnfi'></div></td></acronym><address id='dda5'><big id='5nvi'><big id='u8nw0'></big><legend id='1jwp'></legend></big></address>

              <i id='o355o3'><div id='704g1'><ins id='7vbfn'></ins></div></i>
              <i id='bmk4bq'></i>
            1. <dl id='obo5o5'></dl>
              1. <blockquote id='4p97'><q id='8pba'><noscript id='utfm6i'></noscript><dt id='kate'></dt></q></blockquote><noframes id='5k1o'><i id='yxitj2'></i>


                Clinical indications

                Family with a history genetic disease

                Patients with atypical disease characteristics without diagnosis

                Patients with physical and mental disabilities

                Couples who want to check the reason of recurrent miscarriage or stillbirth

                Patients who have failed to find a genetic cause by clinical exome sequencing


                Wet lab (Genomic DNA)

                Illumina NovaSeq 6000; Capture based tech (nano WES / IDT / Agilent probe)

                Average 100X sequencing coverage, Q30 > 90%, 20X coverage rate > 95%

                Dry lab (Bioinformatics)

                VeritaTrekker® Variants Detection System (SNVs, CNVs, InDels)

                Enliven® Data Annotation and Interpretation System

                Cruxome Interface®

                Case sharing

                Two female siblings originally diagnosed with "cerebral palsy" had received long-term treatment with no significant improvement in perennial paralysis and language skills. Family WES tests found that both girls inherited pathogenic mutations in the GCH1 gene associated with the metabolic disease Dopa-responsive dystonia (DRD). Both girls have now been successfully effectively treated by oral Medopa (Benserazide-Levodopa), reducing the severity of symptoms and improving their quality of life. This case fully demonstrates the important role of WES in the precise diagnosis and treatment of genetic diseases.

                Why choose Berry Genomics for WES

                Integrated professional teams for sequencing, data analysis and reporting

                Fast turnaround time

                Comprehensive disease report for clinical geneticist, including supplementary file listing all potentially pathogenic mutations

                Option of uploading raw data by Cloud to local hospitals for secure storage and reanalysis options

                Competitive pricing

                The clinical significance of WES/CES

                Can provide a precise diagnosis for children with unexplained phenotypes where previous testing has failed to give the answer

                Can help explain the genetic basis of fetal structural abnormalities detected by ultrasound during pregnancy

                Can point the way to potential treatment options for children to improve their health and quality of life

                Can guide the development of prenatal and preimplantation genetic tests so couples

                can confidently proceed to have a second child free of the familial disease condition